Massachusetts General Hospital
Boston, United States
Scott Plotkin, MD, PhD, is Armenise Family Professor of Neurology at Harvard Medical School and is the Executive Director of Stephen E. and Catherine Pappas Center for Neuro-Oncology at Massachusetts General Hospital. He graduated magna cum laude from Harvard University and received an MD and PhD (neuroscience) from Tulane University School of Medicine. He completed his internship in internal medicine at Tulane and then neurology residency at Massachusetts General Hospital and Brigham & Women’s Hospital in Boston, MA. Upon completion of his residency, Dr. Plotkin completed a clinical fellowship in neuro-oncology at Massachusetts General Hospital and was a post-doctoral fellow at the Schepens Eye Research Institute of Harvard Medical School.
Dr. Plotkin’s research focuses on developing clinical trials for patients with NF1 and schwannomatosis (including NF2-related schwannomatosis). He has served as principle investigator on single and multi-center clinical trials and is an active member of several national consortia. In 2011, he co-founded the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration. This collaboration has published consensus recommendations for clinical trial endpoints in trials for NF patients and continues to work closely with the FDA, Cancer Therapy Evaluation Program, and other agencies. He is the principal investigator on multiple federal grants including a neuro-oncology specific K12 training grant and is overall principal investigator for the INTUITT-NF2, an adaptive platform-basket trial for patients with NF2-related schwannomatosis.